GGUF parser vulnerabilities disclosed May 15, 2026 include a critical integer overflow that lets any malicious model file ...

Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...

Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Abstract: This study presents a Python-based framework for converting IFC data into RDF triples, ensuring semantic integrity and interoperability in BIM environments. Using the SemanIFC library for ...

The National Security Agency is said to be using Mythos Preview, Anthropic’s recently announced model that it withheld from public release, Axios reports. The news comes weeks after the NSA’s parent ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

When Jared Hewitt’s co-worker claimed last winter that Hewitt used AI to write an incident report, she did it publicly. “And I work at a day care, so she was berating me in front of children,” he says ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...